Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    66.7%

    Based on 2 completed trials

    Completion Rate
    67%(2/3)
    Active Trials
    0(0%)
    Results Posted
    50%(1 trials)
    Terminated
    1(33%)

    Phase Distribution

    Phase 2
    1
    33%
    Phase 3
    2
    67%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    2

    Late Stage

    Phase Distribution3 total trials
    Phase 2Efficacy & side effects
    1(33.3%)
    Phase 3Large-scale testing
    2(66.7%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    66.7%

    2 of 3 finished

    Non-Completion Rate

    33.3%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Terminated(1)

    Detailed Status

    Completed2
    Terminated1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    66.7%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 21 (33.3%)
    Phase 32 (66.7%)

    Trials by Status

    completed267%
    terminated133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    completedphase_2

    Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

    NCT03451045
    completedphase_3

    Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

    NCT03813160
    terminatedphase_3

    Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

    NCT03398837

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT03451045Phase 2

    Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

    Completed
    NCT03813160Phase 3

    Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

    Completed
    NCT03398837Phase 3

    Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

    Terminated

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3